Regulation of Inflammatory Genes in Hidradenitis Suppurativa

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-89
SponsorUniversity of Alabama at Birmingham

About this trial

The purpose of this protocol is to examine the cytokine profi le of pati ents with hidradeniti s suppurati va (HS) and idemechanisms responsible for post-transcripti onal regulati on of these genes. The primary objecti ve is to determinfollowing cytokines linked to hidradeniti s suppurati va are diff erenti ally expressed in hidradeniti s pati ents versus controlalso doing a sub-study to determine the eff ect of childhood trauma on HS. The parti cipati on in the sub-study is opti onal

Eligibility criteria

Qualifiers

Diagnosed with hidradenitis suppurativa

Not Pregnant

Disqualifiers

Mild/general dermatological issues like moles, other cosmetic issues

Patients with hidradenitis suppurativa, psoriasis, roasacea, atopic dermatitis and other inflammatory skin disease

Pregnant

Trial design

Treatments tested in this trial

  • Mental health

Treatment groups

200 Participants
are divided into 2 treatment groups